These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24142574)

  • 1. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Kadlubar SA
    J Surg Oncol; 2013 Nov; 108(6):335-6. PubMed ID: 24142574
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
    J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant.
    Benusiglio PR; Luccarini C; Ajai O; Ponder BA; Pharoah PD
    Carcinogenesis; 2005 Dec; 26(12):2213. PubMed ID: 16014700
    [No Abstract]   [Full Text] [Related]  

  • 4. A bias in genotyping the ERBB2 (HER2) Ile655Val variant.
    Frank B; Hemminki K; Burwinkel B
    Carcinogenesis; 2005 Sep; 26(9):1649. PubMed ID: 15860504
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
    Stanton SE; Ward MM; Christos P; Sanford R; Lam C; Cobham MV; Donovan D; Scheff RJ; Cigler T; Moore A; Vahdat LT; Lane ME; Chuang E
    BMC Cancer; 2015 Apr; 15():267. PubMed ID: 25885598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.
    Toomey S; Madden SF; Furney SJ; Fan Y; McCormack M; Stapleton C; Cremona M; Cavalleri GL; Milewska M; Elster N; Carr A; Fay J; Kay EW; Kennedy S; Crown J; Gallagher WM; Hennessy BT; Eustace AJ
    Oncotarget; 2016 Nov; 7(46):75518-75525. PubMed ID: 27776352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
    Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
    Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.
    Furrer D; Lemieux J; Côté MA; Provencher L; Laflamme C; Barabé F; Jacob S; Michaud A; Diorio C
    Breast; 2016 Dec; 30():191-196. PubMed ID: 27788409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
    Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Huang BF; Tzeng HE; Chen PC; Wang CQ; Su CM; Wang Y; Hu GN; Zhao YM; Wang Q; Tang CH
    Int J Med Sci; 2018; 15(6):580-586. PubMed ID: 29725248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu gene codon 655 (Ile/Val) polymorphism in breast carcinoma patients.
    Sezgin E; Sahin FI; Yagmurdur MC; Demirhan B
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):143-6. PubMed ID: 21204706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in India: a continuing challenge.
    Gupta S
    Indian J Cancer; 2010; 47(1):1-2. PubMed ID: 20071780
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
    Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
    Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
    Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).
    Wenandy L; Kollgaard T; Letsch A; Andersen RS; Stather D; Seremet T; Svane IM; Vindeløv L; Andersen MH; thor Straten P
    Leukemia; 2009 Oct; 23(10):1926-9. PubMed ID: 19458631
    [No Abstract]   [Full Text] [Related]  

  • 16. A putative molecular-activation switch in the transmembrane domain of erbB2.
    Fleishman SJ; Schlessinger J; Ben-Tal N
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15937-40. PubMed ID: 12461170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
    Kauraniemi P; Kallioniemi A
    Endocr Relat Cancer; 2006 Mar; 13(1):39-49. PubMed ID: 16601278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional characteristics of erbB2 in normal and cancer breast cells.
    Tommasi S; Fedele V; Lacalamita R; Crapolicchio A; Perlino E; Bellizzi A; Paradiso A
    Cancer Lett; 2004 Jun; 209(2):215-22. PubMed ID: 15159024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on ERBB2.
    Benusiglio PR
    Pharmacogenomics; 2008 Jul; 9(7):825-8. PubMed ID: 18597646
    [No Abstract]   [Full Text] [Related]  

  • 20. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.